Home > Healthcare > Image Guided Radiotherapy Market > Table of Contents

Image Guided Radiotherapy Market – By Product Type (Radiotherapy/LINAC Devices, Imaging Devices), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Brain Tumor, Gastrointestinal Cancer, Gynecological Cancer), End-use & Forecast, 2024 – 2032

  • Report ID: GMI9195
  • Published Date: Apr 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1   Market scope & definitions

1.2   Research design

1.2.1   Research approach

1.2.2   Data collection methods

1.3   Base estimates & calculations

1.3.1   Base year calculation

1.3.2   Key trends for market estimation

1.4   Forecast model

1.5   Primary research and validation

1.5.1   Primary sources

1.5.2   Data mining sources

Chapter 2   Executive Summary

2.1   Industry 360synopsis

Chapter 3   Industry Insights

3.1   Industry ecosystem analysis

3.2   Industry impact forces

3.2.1   Growth drivers

3.2.1.1   Increasing incidence of cancer

3.2.1.2   Technological advancements in radiotherapy devices

3.2.1.3   Surging preference for personalized treatment planning

3.2.1.4   Rise in adoption of non-invasive cancer treatment

3.2.2   Industry pitfalls & challenges

3.2.2.1   Radiation exposure and safety concerns

3.2.2.2   High cost of cancer treatment

3.3   Growth potential analysis

3.4   Regulatory landscape

3.5   Technological landscape

3.6   Future market trends

3.7   Porter's analysis

3.8   PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1   Introduction

4.2   Company market share analysis

4.3   Company matrix analysis

4.4   Competitive analysis of major market players

4.5   Competitive positioning matrix

4.6   Strategy dashboard

Chapter 5   Market Estimates and Forecast, By Product Type, 2021 – 2032 ($ Mn)

5.1   Key trends

5.2   Radiotherapy devices

5.2.1   LINAC (Linear Accelerators)

5.3   Imaging devices

5.3.1   CT scan

5.3.2   MRI

5.3.3   PET scan

5.3.4   Other imaging devices

Chapter 6   Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)

6.1   Key trends

6.2   Breast cancer

6.3   Lung cancer

6.4   Brain tumor

6.5   Prostate cancer

6.6   Gastrointestinal cancer

6.7   Gynecological cancer

6.8   Other applications

Chapter 7   Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)

7.1   Key trends

7.2   Hospitals

7.3   Radiotherapy centers

7.4   Other end-users

Chapter 8   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

8.1   Key trends

8.2   North America

8.2.1    U.S.

8.2.2    Canada

8.3   Europe

8.3.1    Germany

8.3.2    UK

8.3.3    France

8.3.4    Spain

8.3.5    Italy

8.3.6    Netherlands

8.3.7    Rest of Europe

8.4   Asia Pacific

8.4.1    China

8.4.2    Japan

8.4.3    India

8.4.4    Australia

8.4.5    South Korea

8.4.6    Rest of Asia Pacific

8.5   Latin America

8.5.1    Brazil

8.5.2    Mexico

8.5.3    Argentina

8.5.4    Rest of Latin America

8.6   Middle East and Africa

8.6.1    South Africa

8.6.2    Saudi Arabia

8.6.3    UAE

8.6.4    Rest of Middle East and Africa

Chapter 9   Company Profiles

9.1    Accuray Incorporated

9.2    C-RAD

9.3    Elekta

9.4    GE Healthcare

9.5    Hitachi, Ltd.

9.6    Philips

9.7    Siemens Healthineers

9.8    Varian Medical Systems, Inc.

9.9    ViewRay, Inc.

9.10    Vision RT Ltd.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 151
  • Countries covered: 23
  • Pages: 110
 Download Free Sample